Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes

被引：11

作者：

Tamburini, J. ^{[1
]}

Elie, C. ^{[2
]}

Park, S. ^{[1
]}

Beyne-Rauzy, O. ^{[3
]}

Gardembas, M. ^{[4
]}

Berthou, C. ^{[5
]}

Mahe, B. ^{[6
]}

Sanhes, L. ^{[7
]}

Stamatoullas, A. ^{[8
]}

Vey, N. ^{[9
]}

Aouba, A.

Slama, B. ^{[10
]}

Quesnel, B. ^{[11
]}

Vekhoff, A. ^{[13
]}

Sotto, J. J. ^{[12
]}

Vassilief, D. ^{[1
]}

Al-Nawakil, C. ^{[1
]}

Fenaux, P. ^{[14
]}

Dreyfus, F. ^{[1
]}

Bouscary, D. ^{[1
]}

机构：

[1] Hop Cochin, Dept Haematol, Paris, France

[2] Univ Paris 05, Dept Biostat, F-75270 Paris 06, France

[3] Hop Purpan, Dept Hematol Odile, Toulouse, France

[4] Ctr Hosp Angers, Dept Hematol Martine, Angers, France

[5] Hop Brest, Dept Hematol Christian, Brest, France

[6] Ctr Hosp Nantes, Dept Hematol, Nantes, France

[7] Ctr Hosp Perpignan, Dept Hematol, Perpignan, France

[8] Ctr Hosp Rouen, Dept Hematol Aspasia, Rouen, France

[9] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France

[10] Ctr Hosp Avignon, Dept Hematol, Avignon, France

[11] Ctr Hosp Lille, Dept Hematol, Lille, France

[12] Ctr Hosp Grenoble, Dept Hematol, Grenoble, France

[13] Hop Hotel Dieu, Dept Hematol, F-75181 Paris, France

[14] Hop Avicenne, Dept Hematol, Bobigny, France

来源：

LEUKEMIA RESEARCH | 2009年 / 33卷 / 04期

关键词：

INTERNATIONAL WORKING GROUP; RESPONSE CRITERIA; ANEMIA; PROPOSAL;

D O I：

10.1016/j.leukres.2008.06.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：547 / 550

页数：4

共 13 条

[1] A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Francais des Myelodysplasies [J].

Bouscary, D ;

Legros, L ;

Tulliez, M ;

Dubois, S ;

Mahe, B ;

Beyne-Rauzy, O ;

Quarre, MC ;

Vassilief, D ;

Varet, B ;

Aouba, A ;

Gardembas, M ;

Giraudier, S ;

Guerci, A ;

Rousselot, P ;

Gaillard, F ;

Moreau, A ;

Rousselet, MC ;

Ifrah, N ;

Fenaux, P ;

Dreyfus, F .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (05) :609-618

[2]

Cheson BD, 2000, BLOOD, V96, P3671

[3] Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia [J].

Cheson, Bruce D. ;

Greenberg, Peter L. ;

Bennett, John M. ;

Lowenberg, Bob ;

Wijermans, Pierre W. ;

Nimer, Stephen D. ;

Pinto, Antonio ;

Beran, Miloslav ;

de Witte, Theo M. ;

Stone, Richard M. ;

Mittelman, Moshe ;

Sanz, Guillermo F. ;

Gore, Steven D. ;

Schiffer, Charles A. ;

Kantarjian, Hagop .

BLOOD, 2006, 108 (02) :419-425

[4]

Garcia-Manero Guillermo, 2007, Clin Adv Hematol Oncol, V5, P1

[5] Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model [J].

HellstromLindberg, E ;

Negrin, R ;

Stein, R ;

Krantz, S ;

Lindberg, G ;

Vardiman, J ;

Ost, A ;

Greenberg, P .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :344-351

[6] Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes [J].

Musto, P ;

Lanza, F ;

Balleari, E ;

Grossi, A ;

Falcone, A ;

Sanpaolo, G ;

Bodenizza, C ;

Scalzulli, PR ;

La Sala, A ;

Campioni, D ;

Ghio, R ;

Cascavilla, N ;

Careha, AM .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (02) :204-209

[7] Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives [J].

Musto, P .

LEUKEMIA RESEARCH, 2004, 28 (04) :325-332

[8]

Musto P, 2002, HAEMATOLOGICA, V87, P884

[9] Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF:: the GFM experience [J].

Park, Sophie ;

Grabar, Sophie ;

Kelaidi, Charikleia ;

Beyne-Rauzy, Odile ;

Picard, Francoise ;

Bardet, Valerie ;

Coiteux, Valerie ;

Leroux, Genevieve ;

Lepelley, Pascale ;

Daniel, Marie-Therese ;

Cheze, Stephane ;

Mahe, Beatrice ;

Ferrant, Augustin ;

Ravoet, Christophe ;

Escoffre-Barbe, Martine ;

Ades, Lionel ;

Vey, Norbert ;

Aljassern, Lina ;

Stamatoullas, Aspasia ;

Mannone, Lionel ;

Dombret, Herve ;

Bourgeois, Keith ;

Greenberg, Peter ;

Fenaux, Pierre ;

Dreyfus, Francois .

BLOOD, 2008, 111 (02) :574-582

[10] Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes [J].

Raza, A ;

Meyer, P ;

Dutt, D ;

Zorat, F ;

Lisak, L ;

Nascimben, F ;

du Randt, M ;

Kaspar, C ;

Goldberg, C ;

Loew, J ;

Dar, S ;

Gezer, S ;

Venugopal, P ;

Zeldis, J .

BLOOD, 2001, 98 (04) :958-965

← 1 2 →